Fig. 7.
Summary of the changes with angiotensin receptor blocker (ARB) treatment in both not cognitively impaired and Alzheimer’s dementia participants. ACE, angiotensin-converting enzyme; Ang, angiotensin; ARB, angiotensin receptor blocker; AP-A, aminopeptidase A; AP-N, aminopeptidase N; AT1R, angiotensin II type 1 receptor; AT2R, angiotensin II type 2 receptor; AT4R, angiotensin type 4 receptor